Future studies will focus on understanding how the metabolic pathway is impaired in mutant p53 CLL cells, with special attention to the modulation of glutathione-related proteins (such as SLC7A11). This evidence concerns the gene SLC7A11 and B-cell chronic lymphocytic leukemia.